Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
hematopoietic stem cell mobilization
MeSH D019650 - hematopoietic stem cell mobilization
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D001691:
Biological therapy
0 Companies
0 Drugs
Success rate
D019650:
Hematopoietic stem cell mobilization
1 Company
1 Drug
$
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
BioLineRx
Motixafortide
Aphexda
2023-09-08
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/1
Phase 3
0
%
0/0
Approved:
0
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
BioLineRx
Motixafortide
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use